The Science Team at Engitix Therapeutics leverages their expertise in drug discovery, tissue engineering, and translational biology to advance the company's portfolio of programs targeting fibrosis and solid tumors. This team utilizes the company's human extracellular matrix (ECM)-based discovery platform to develop innovative therapeutic solutions, bringing together a multidisciplinary group of scientists and advisors to drive research and development.
View all